Estados Unidos · Plataformas y datos · Finviz

Travere Therapeutics Reports Third Quarter 2026 Financial Results

Publicado por Finviz · Estados Unidos hace 9 h

(Nasdaq: TVTX) today reported its third quarter 2026 financial results and provided a corporate update. “Strong execution across our business drove another quarter of significant…

Leer el artículo completo en Finviz Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finviz.com)

Travere Therapeutics Reports Third Quarter 2026 Financial Results

También te puede interesar

MSA Safety beats top-line estimates; reaffirms FY26 outlook

Kosmos Energy (KOS) Q3 2026 Earnings Call Transcript

SLB (NYSE:SLB) Stock Breaks Below 50 Day Moving Average After Insider Selling

Australian, Chinese airline stocks jump as oil prices plunge more than 7%

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

Stock market after midterm elections: What S&P 500 history shows

Travere Therapeutics Reports Third Quarter 2026 Financial Results

Compartir

También te puede interesar

MSA Safety beats top-line estimates; reaffirms FY26 outlook

Kosmos Energy (KOS) Q3 2026 Earnings Call Transcript

SLB (NYSE:SLB) Stock Breaks Below 50 Day Moving Average After Insider Selling

Australian, Chinese airline stocks jump as oil prices plunge more than 7%

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

Stock market after midterm elections: What S&P 500 history shows